So Ryan, how does PI work into everything with the pharmacy end of this world? How do those two worlds combine?

Sure.

Really, it's about just trying to help with what workflows can support really the distribution of utilizing pharmacogenomics and pharmacogenomics is really an interesting piece in the personalized medicine space where it's a little different than the other things that we're working on, whereas your genetic makeup may make you predisposed to certain cancers or certain conditions that we're also looking at.

But this is more on the treatment side of things.

Are we using the right drug? Are we using the right dose? It's a very interesting space in that.

So what our team is trying to do is help How do we best get this at the hands of those providers, those clinicians, to help these patients in the most efficient manner possible is really what we're trying to do.

That's just how fast it's changing.

And that's kind of what's exciting really for the future as we now have a genomics module within our electronic medical record that can help facilitate some of this.